NCT03431350 2025-12-23QUESTJanssen Research & Development, LLCPhase 2 Active not recruiting136 enrolled 29 charts
NCT02254785 2017-12-06Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate CancerBritish Columbia Cancer AgencyPhase 2 Unknown120 enrolled